Company
Bio Essence Corp (BIOE)
Standardized SEC financial data for Bio Essence Corp — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001723059 · OTC · Pharmaceutical Preparations.
Gross margin
75.3%
Operating margin
47.4%
Net margin
47.2%
Revenue growth (YoY)
485.8%
Return on equity
-43.2%
Free cash flow
$1.6M
Debt / equity
-0.03×
Current ratio
0.17×
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $959K | $888K | $622K | $552K | $324K | $1.9M |
| Cost of revenue |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $5K | $303 | $6K | $114 | $1K | — |
| Inventory |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$733K | -$1.3M | -$703K | -$1.0M | $640K | $1.6M |
| Capital expenditures |
Get BIOE data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/BIOE/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/BIOE/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"